IRCT2016101030248N1 IRCT 2016-11-17 Vice chancellor for research, Urmia University of Medical Sciences Assessment of vitamin D oral supplementationon on insulin resistance, visceral fat and adiponectin in women with polycystic ovary syndrome and hypovitaminosis D Assessment of vitamin D oral supplementation on insulin resistance, visceral fat and adiponectin in women with polycystic ovary syndrome and hypovitaminosis D 2016-05-21 anticipated 44 Complete https://irct.ir/trial/24098 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Other design features: In order to avoid the possible effect of awareness of allocation to treatment or placebo groups a single blind design was used which only researcher was awareness of randomizing into two groups. According to the number's of randomized table, we put patient into two groups and they did not know any things about this. 2 Polycystic Ovary Syndrome. Intervention 1: Intervention: 8 vitamin D3 capsule 50000 IU during 2 month (1 capsule in the week after lunch). Intervention 2: Control: 8 placebo capsule(Paraffinedible) during 2 month (1 capsule in the week after lunch).